Search Results - "Moles, Victor M."

  • Showing 1 - 19 results of 19
Refine Results
  1. 1
  2. 2

    Barriers to physical activity in patients with pulmonary hypertension by Cascino, Thomas M., McLaughlin, Vallerie V., Richardson, Caroline R., Behbahani-Nejad, Nilofar, Moles, Victor M., Visovatti, Scott H., Jackson, Elizabeth A.

    Published in Pulmonary circulation (01-04-2019)
    “…Patients with pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) have low levels of physical activity (PA)…”
    Get full text
    Journal Article
  3. 3

    Current status and barriers in pulmonary hypertension care delivery in India: A qualitative analysis by Maligireddy, Anand Reddy, Shore, Supriya, Sreenivas Kumar, A., Harikrishnan, S., Ajit Mullasari, S., Sastry, B. K., Gupta, Sameer, Choudhary, Nikhil, Atreya, Auras R., Arora, Sonali, Moles, Victor M., Mclaughlin, Vallerie V., Aggarwal, Vikas

    Published in Pulmonary circulation (01-04-2022)
    “…Although pulmonary hypertension (PH) is widely prevalent in India, care delivery for this condition has unique challenges in a lower middle‐income country…”
    Get full text
    Journal Article
  4. 4
  5. 5

    A new day has come: Sotatercept for the treatment of pulmonary arterial hypertension by Cascino, Thomas M., Sahay, Sandeep, Moles, Victor M., McLaughlin, Vallerie V.

    “…Despite increasing therapeutic options and evolving treatment strategies, including targeting 3 therapeutic pathways, in the management of pulmonary arterial…”
    Get full text
    Journal Article
  6. 6

    Performance of the DETECT Algorithm for Pulmonary Hypertension Screening in a Systemic Sclerosis Cohort by Young, Amber, Moles, Victor M., Jaafar, Sara, Visovatti, Scott, Huang, Suiyuan, Vummidi, Dharshan, Nagaraja, Vivek, McLaughlin, Vallerie, Khanna, Dinesh

    Published in Arthritis & rheumatology (Hoboken, N.J.) (01-09-2021)
    “…Objective Pulmonary arterial hypertension (PAH) is one of the leading causes of mortality in systemic sclerosis (SSc). This study was undertaken to assess…”
    Get full text
    Journal Article
  7. 7

    Considerations for Inotrope and Vasopressor Use in Critically Ill Patients With Pulmonary Arterial Hypertension by Adie, Sarah K., Abdul-Aziz, Ahmad A., Ketcham, Scott W., Moles, Victor M.

    Published in Journal of cardiovascular pharmacology (01-01-2022)
    “…Pulmonary arterial hypertension (PAH) is a rare and progressive cardiopulmonary disease, characterized by pulmonary vasculopathy. The disease can lead to…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12

    Safety of regadenoson stress testing in patients with pulmonary hypertension by Moles, Victor M., Cascino, Thomas, Saleh, Ashraf, Mikhova, Krasimira, Lazarus, John J., Ghannam, Michael, Yun, Hong J., Konerman, Matthew, Weinberg, Richard L., Ficaro, Edward P., Corbett, James R., McLaughlin, Vallerie V., Murthy, Venkatesh L.

    Published in Journal of nuclear cardiology (01-06-2018)
    “…We sought to determine the safety of regadenoson stress testing in patients with PH. PH is increasingly recognized at more advanced ages. As many as one-third…”
    Get full text
    Journal Article
  13. 13

    Pulmonary Hypertension in Women: What Does the Cardiologist Need to Know? by Moles, Victor M., McLaughlin, Vallerie V.

    Published in Current cardiovascular risk reports (01-03-2017)
    “…Purpose of Review Our goal is to review the epidemiology, diagnosis, and management of PH focusing on how this condition affects women. Recent Findings PH is a…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Exercise Training in Patients with Chronic Thromboembolic Pulmonary Hypertension and Pulmonary Arterial Hypertension by VanAken, Gabriella, Rubick, Drew, Wieczorek, Daniel, Chatterjee, Saurav, Moles, Victor M., Agarwal, Prachi P., Haft, Jonathan W., Cascino, Thomas M., Visovatti, Scott H., Aggarwal, Vikas

    Published in Heart failure clinics (01-01-2025)
    “…Of the 5 randomized controlled trials (RCTs) included, chronic thromboembolic pulmonary hypertension (CTEPH) patients constituted 20% of the overall pulmonary…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19